General Information of the Compound
Compound ID
CP0407035
Compound Name
1-(2-Pyridin-3-yl-quinazolin-4-yl)-3-o-tolyl-urea
    Show/Hide
Structure
Formula
C21H17N5O
Molecular Weight
355.401
Canonical SMILES
Cc1ccccc1NC(=O)Nc1nc(nc2ccccc12)-c1cccnc1
    Show/Hide
InChI
InChI=1S/C21H17N5O/c1-14-7-2-4-10-17(14)24-21(27)26-20-16-9-3-5-11-18(16)23-19(25-20)15-8-6-12-22-13-15/h2-13H,1H3,(H2,23,24,25,26,27)
    Show/Hide
InChIKey
ZGKXGTYTAWZKGP-UHFFFAOYSA-N
Physicochemical Property
logP
4.64422
Rotatable Bonds
3
Heavy Atom Count
27
Polar Areas
79.8
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10665887
SID: 15698537
ChEMBL ID
CHEMBL72172
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01279, Adenosine receptor A3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 23900 nM
   TI
   LI
   LO
   TS